Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Institute of Endocrinology and Metabolism, Kiev, Ukraine.
J Clin Endocrinol Metab. 2019 Jan 1;104(1):41-48. doi: 10.1210/jc.2018-00847.
Children and adolescents exposed to radioactive iodine-131 (I-131) in fallout from the 1986 Chernobyl nuclear accident appear to be at increased risk of thyroid cancer and benign thyroid nodules. The prenatal period is also considered radiosensitive, and the fetal thyroid can absorb I-131 from the maternal circulation.
We aimed to estimate the risk of malignant and benign thyroid nodules in individuals exposed prenatally.
We studied a cohort of 2582 subjects in Ukraine with estimates of I-131 prenatal thyroid dose (mean = 72.6 mGy), who underwent two standardized thyroid screening examinations. To evaluate the dose-response relationship, we estimated the excess OR (EOR) using logistic regression.
Based on a combined total of eight cases diagnosed at screenings from 2003 to 2006 and 2012 to 2015, we found a markedly elevated, albeit not statistically significant, dose-related risk of thyroid cancer (EOR/Gy = 3.91, 95% CI: -1.49, 65.66). At cycle 2 (n = 1,786), there was a strong and significant association between I-131 thyroid dose and screen-detected large benign nodules (≥10 mm) (EOR/Gy = 4.19, 95% CI: 0.68, 11.62; P = 0.009), but no significant increase in risk for small nodules (<10 mm) (EOR/Gy = 0.34, 95% CI: -0.67, 2.24; P = 0.604).
The dose effect by nodule size, with I-131 risk for large but not small nodules, is similar to that among exposed children and adolescents in Belarus. Based on a small number of cases, there is also a suggestive effect of I-131 dose on thyroid cancer risk.
儿童和青少年在切尔诺贝利核事故的放射性碘-131(I-131)沉降物中受到照射,其甲状腺癌和良性甲状腺结节的风险似乎增加。孕期也被认为是辐射敏感的,胎儿甲状腺可以从母体循环中吸收 I-131。
我们旨在评估产前暴露个体中恶性和良性甲状腺结节的风险。
我们研究了乌克兰的一个 2582 名受试者队列,他们的 I-131 产前甲状腺剂量(平均值=72.6mGy)有估计值,并接受了两次标准化的甲状腺筛查检查。为了评估剂量反应关系,我们使用逻辑回归估计了过量比值比(EOR)。
根据 2003 年至 2006 年和 2012 年至 2015 年筛查中总共 8 例确诊病例,我们发现甲状腺癌的风险明显升高,尽管没有统计学意义(EOR/Gy=3.91,95%CI:-1.49,65.66)。在第 2 周期(n=1786)中,I-131 甲状腺剂量与筛查发现的大良性结节(≥10mm)之间存在强烈且显著的关联(EOR/Gy=4.19,95%CI:0.68,11.62;P=0.009),但小结节(<10mm)的风险没有显著增加(EOR/Gy=0.34,95%CI:-0.67,2.24;P=0.604)。
根据结节大小的剂量效应,I-131 对大结节有风险,而对小结节没有风险,这与白俄罗斯暴露儿童和青少年的情况相似。基于少数病例,I-131 剂量对甲状腺癌风险也有提示作用。